• Search results for Serum
Image Title
spu1200

Serum Institute to start manufacturing Sputnik vaccine in September 

Serum Institute of India (SII) will start production of Sputnik vaccine at the company's facilities in September, Russian Direct Investment Fund (RDIF) said on Tuesday

Published on 13th July 2021
Covishield_(1)

India pushes Italy to recognise CoWIN certificate for Covishield

Italy is not on the list of countries that have given a "green pass" to the Astra-Zeneca vaccine manufactured by the Serum Institute of India 

Published on 10th July 2021
COVID-19-Vaccine-6-3

Indian government dismisses reports that Covaxin may hamper plans to travel abroad

Multiple reports had said that over 130 countries across the globe currently accept Serum Institute of India's Covishield vaccine to enter their country while Covaxin is accepted in only nine n

Published on 22nd May 2021
covid_vaccine

JD Institute rolls out free COVID vaccination camp for employees above 18 years 

The employees received the Covishield vaccine, developed by the Oxford-AstraZeneca and manufactured by the Serum Institute of India

Published on 7th May 2021
pic

No data to show Covishield, Covaxin can protect against new virus strain: Union Minister

The Central Drugs Standard Control Organisation (CDSCO) under the Ministry of Health has given approval to Serum Institute of India for manufacture of its COVID-19 vaccine for restricted use

Published on 2nd February 2021
covaxin-1603676480

Bharat Biotech seeks DCGI's approval to conduct trials of nasal COVID-19 vaccine

COVID-19 vaccines of Serum Institute of India's 'Covishield' and Bharat Biotech's 'Covaxin' were granted permission for restricted use in an emergency situation by the DCGI on January 3

Published on 8th January 2021
Proper-storage-temperature-is-crucial-to-vaccine-potency

UK's Oxford vaccine Phase-2 trial indicates strong results in older adults, says Lancet study

The Oxford Covid-19 vaccine has collaborated with Indian drug maker--Serum Institute of India (SII) for which phase 2 clinical trials are being conducted in India also

Published on 19th November 2020
Proper-storage-temperature-is-crucial-to-vaccine-potency

Covishield availability reports are false, conjectural: Serum Institute on Oxford vaccine

"Covishield will be commercialised once the trials are proven successful and all the requisite regulatory approvals are in place," Serum Institue of India said

Published on 23rd August 2020
download_(4)

COVID-19 cases haven't yet peaked or even plateaued: AIIMS Director

Three vaccine candidates are in different stages of human clinical trials in India — one developed by University of Oxford by Pune's Serum Institute of India, the other inactivated virus vaccine

Published on 12th August 2020

Search results 1 - 9 of 105